Seer (SEER) Stock Price, News & Analysis

Company Overview

Seer, Inc. is a life sciences company that develops technologies for large-scale protein analysis, or proteomics. Its platform is designed to help researchers study the proteins present in biological samples and generate insights into disease biology, drug discovery and the development of precision medicine.

The company’s principal offering is the Proteograph Product Suite, which combines proprietary nanoparticle technology with automation, software and next-generation sequencing or mass spectrometry workflows. Seer also provides related consumables, instruments, software and services intended to support sample processing, data generation and interpretation.

Seer’s products are used by pharmaceutical and biotechnology companies, academic and research institutions, and other organizations involved in biomedical research. The company was founded in 2017 and is headquartered in Redwood City, California, serving customers in the United States and international markets. Seer is led by co-founder and Chief Executive Officer Omid Ghodsi.

Key Stats

• Today's Range: $2.14 to $2.25
• 50-Day Range: $1.80 to $2.33
• 52-Week Range: $1.55 to $2.41
• Volume: 204,197 shs
• Average Volume: 324,694 shs
• Market Capitalization: $121.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Buy

Seer Stock Analysis - MarketRank™

Seer scored higher than 55% of companies evaluated by MarketBeat, and ranked 470th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Seer has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Seer has a consensus price target of $4.00, representing about 82.6% upside from its current price of $2.19.

Amount of Analyst Coverage

Seer has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Seer is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Seer is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Seer has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.22% of the float of Seer has been sold short.

Short Interest Ratio / Days to Cover

Seer has a short interest ratio ("days to cover") of 0.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Seer has recently increased by 24.36%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Seer does not currently pay a dividend.

Dividend Growth

Seer does not have a long track record of dividend growth.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

Seer has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Seer this week, compared to 4 articles on an average week.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Seer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,837.00 in company stock.

Percentage Held by Insiders

11.28% of the stock of Seer is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

75.20% of the stock of Seer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:SEER
• CIK: 1726445
• Web: www.seer.bio
• Phone: 650-453-0000
• Fax: N/A
• Employees: 124
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Seer: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +82.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$73.60 million
• Net Margins: -478.05%
• Pretax Margin: -477.55%
• Return on Equity: -27.23%
• Return on Assets: -23.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 14.74
• Quick Ratio: 14.06

Sales & Book Value

• Annual Sales: $16.58 million
• Price / Sales: 7.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.61 per share
• Price / Book: 0.48

Miscellaneous

• Outstanding Shares: 55,370,000
• Free Float: 49,126,000
• Market Cap: $121.26 million
• Optionable: Optionable
• Beta: 1.47